Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PBP World MeetingPBP World Meeting
Not Confirmed
Not Confirmed
23-26 March, 2026
Not Confirmed
Not Confirmed
23-24 March, 2026
European Pharma Congre...European Pharma Congress
Not Confirmed
Not Confirmed
23-24 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PBP World MeetingPBP World Meeting
Industry Trade Show
Not Confirmed
23-26 March, 2026
Industry Trade Show
Not Confirmed
23-24 March, 2026
European Pharma Congre...European Pharma Congress
Industry Trade Show
Not Confirmed
23-24 March, 2026
Digital content

12 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/12/3254279/0/en/Full-Year-2025-Trading-Update.html

11 Mar 2026
// FIERCE PHARMA
https://www.fiercepharma.com/marketing/skyhawk-lands-ex-teva-executive-steer-commercial-flight-path

10 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/10/3252430/0/en/Santhera-Appoints-Marc-Clausse-as-Chief-Commercial-Officer-to-Lead-Next-Phase-of-Growth.html

09 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/09/3251502/0/en/AGAMREE-vamorolone-Data-Presented-at-MDA-2026-Confirm-Comparable-Long-Term-Effectiveness-for-up-to-8-Years-of-Treatment-with-Clinically-Meaningful-Safety-Advantages-in-Duchenne-Mus.html

06 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/06/3251009/13009/en/Catalyst-Pharmaceuticals-to-Showcase-Real-World-Findings-in-Duchenne-Muscular-Dystrophy-and-Host-Vamorolone-Focused-Symposium-at-the-2026-MDA-Clinical-Scientific-Conference.html

27 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/27/3246266/0/en/Santhera-Announces-Proposed-Inclusion-and-Reimbursement-of-AGAMREE-Vamorolone-within-Spain-s-National-Health-System-for-the-Treatment-of-Duchenne-Muscular-Dystrophy.html
ABOUT THIS PAGE